
Aceclofenac (100mg) + Serratiopeptidase (15mg) + Paracetamol (325mg)
Active composition
+2 more active ingredients
Aceclofenac inhibits COX-1 and COX-2 enzymes, leading to decreased synthesis of prostaglandins, which are responsible for pain and inflammation.
Serratiopeptidase acts as a proteolytic enzyme, breaking down fibrin and other proteins involved in inflammation, thereby reducing pain and swelling.
Paracetamol works by inhibiting cyclooxygenase (COX) enzymes, leading to reduced synthesis of prostaglandins in the brain, which are responsible for pain and fever.
Medical applications
Wdol-SP Tablet is a combination analgesic formulation containing Aceclofenac 100 mg, Paracetamol 325 mg, and Serratiopeptidase 15 mg, designed to provide effective relief from pain and inflammation. Aceclofenac, a non-steroidal anti-inflammatory drug (NSAID), exerts its action by inhibiting cyclooxygenase enzymes, thereby reducing the synthesis of prostaglandins responsible for pain and inflammation. Paracetamol acts centrally to alleviate pain and reduce fever through inhibition of the prostaglandin synthesis pathway in the central nervous system. Serratiopeptidase, a proteolytic enzyme, facilitates the breakdown of inflammatory mediators and promotes the resolution of edema and tissue inflammation. This synergistic combination is indicated for the management of musculoskeletal disorders such as osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and soft tissue injuries including sprains, strains, and post-operative inflammation. Wdol-SP Tablet offers rapid onset of analgesia along with sustained anti-inflammatory effects, improving patient comfort and mobility. It should be used under medical supervision, considering contraindications such as hypersensitivity to NSAIDs, active peptic ulcer, or bleeding disorders. Caution is advised in patients with hepatic, renal, or cardiovascular impairment. The tablet is typically administered orally, with dosage and duration tailored according to clinical response and physician guidance.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Safety information not available for this product. Please consult your doctor or pharmacist.
0 reviews for Wdol-SP Tablet

Aceclofenac (100mg) + Paracetamol (325mg) + Serratiopeptidase (15mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+2 more active ingredients
Aceclofenac inhibits COX-1 and COX-2 enzymes, leading to decreased synthesis of prostaglandins, which are responsible for pain and inflammation.
Serratiopeptidase acts as a proteolytic enzyme, breaking down fibrin and other proteins involved in inflammation, thereby reducing pain and swelling.
Paracetamol works by inhibiting cyclooxygenase (COX) enzymes, leading to reduced synthesis of prostaglandins in the brain, which are responsible for pain and fever.
Medical applications
Wdol-SP Tablet is a combination analgesic formulation containing Aceclofenac 100 mg, Paracetamol 325 mg, and Serratiopeptidase 15 mg, designed to provide effective relief from pain and inflammation. Aceclofenac, a non-steroidal anti-inflammatory drug (NSAID), exerts its action by inhibiting cyclooxygenase enzymes, thereby reducing the synthesis of prostaglandins responsible for pain and inflammation. Paracetamol acts centrally to alleviate pain and reduce fever through inhibition of the prostaglandin synthesis pathway in the central nervous system. Serratiopeptidase, a proteolytic enzyme, facilitates the breakdown of inflammatory mediators and promotes the resolution of edema and tissue inflammation. This synergistic combination is indicated for the management of musculoskeletal disorders such as osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and soft tissue injuries including sprains, strains, and post-operative inflammation. Wdol-SP Tablet offers rapid onset of analgesia along with sustained anti-inflammatory effects, improving patient comfort and mobility. It should be used under medical supervision, considering contraindications such as hypersensitivity to NSAIDs, active peptic ulcer, or bleeding disorders. Caution is advised in patients with hepatic, renal, or cardiovascular impairment. The tablet is typically administered orally, with dosage and duration tailored according to clinical response and physician guidance.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Safety information not available for this product. Please consult your doctor or pharmacist.
0 reviews for Wdol-SP Tablet











